Pharmaceutical and Industrial Traits in Genetically Modified Crops: Coexistence with Conventional Agriculture
Economics, Center for Agricultural and Rural Development
Journal or Book Title
American Journal of Agricultural Economics
First Page or Article ID Number
The first ten years of commercial experience with genetically modified (GM) crops must be considered a success, albeit a qualified one. Adoption has been remarkable: first commercially planted in 1996, world GM crop planting reached 220 million acres in 2005 (James 2005). But large-scale adoption has been confined to a few crops grown in only a few countries, and the currently widely grown GM crops are all based on only a handful of so-called input traits that confer herbicide tolerance and/or pest resistance. Furthermore, this technology has been met with hostility by some consumer groups and segments of the public. And, the introduction of GM crops means that supplying non-GM products now requires (relative to the pre-innovation situation) additional costly identity preservation and segregation activities (Bullock and Desquilbet 2002). Thus, the innovation process has, in this context, brought about a new market failure, an externality on the production of conventional (non-GM) products (Lapan and Moschini 2004). Such unintended economic implications of the introduction of GM crops are central to the current debate about the “coexistence” of GM and non-GM agriculture.
Moschini, Giancarlo, "Pharmaceutical and Industrial Traits in Genetically Modified Crops: Coexistence with Conventional Agriculture" (2006). Economics Publications. 177.